News

Dr. Rahul Sharma has been recognized with the 2025 Roger Schenke Award by the American Association for Physician Leadership.

Awards, honors and achievements for the month of April.

Teams of health care providers called Accountable Care Organizations participating in the Medicare Shared Savings Program have saved Medicare between $4.1 billion and $8.1 billion from 2012 through 2019, according to a new study from Weill Cornell Medicine investigators. 

Three distinguished Weill Cornell Medicine physician-scientists, Dr. Matthew Greenblatt, Dr. Lishomwa Ndhlovu and Dr. Sallie Permar, have been elected to the prestigious Association of American Physicians (AAP).

A major new effort at Weill Cornell Medicine seeks to catalog the normal human virome, the immense ecosystem of viruses that lives in and on us.

Weill Cornell Medicine investigators are developing a new test for TB that circumvents many of the current diagnostic challenges.

The annual Cornell Ph.D. Student Advocacy Day took on extra significance this year as 16 doctoral students traveled April 9 from the Ithaca campus and Weill Cornell Medicine to Washington, D.C. to meet with Congress members and their staff.

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell Medicine researchers.

A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they divide, a key process in keeping cells healthy. Using yeast, the researchers reveal protein interactions that could explain how the enzyme telomerase is tightly regulated to prevent cells from dividing uncontrollably or aging prematurely.

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators.

Nearly 200 scientists, investors and industry representatives attended Weill Cornell Medicine’s 2025 Biomedical Innovation Conference April 1, sharing their startup journeys and experiences nurturing biomedical advances into health care products and companies.

As chair, Dr. Ehrt seeks to build on the department’s already robust national and international footprint in tuberculosis research and expand its portfolio in other areas of research and innovation.

Dr. Helen Boucher, dean of Tufts University School of Medicine, delivered the Women in Medicine and Science lecture for Weill Cornell Medicine’s seventh annual Diversity Week.   

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a study by Weill Cornell Medicine and New York Genome Center investigators.

Weill Cornell Medicine’s Celebration of Diversity honored leaders who go beyond their official roles, dedicating time, energy and empathy to build inclusive environments. The ceremony, part of the institution’s seventh annual Diversity Week, was held April 7 in Griffis Faculty Club.

Diversity is a tool for truth, not political agendas, said Vincent D. Rougeau,  president of the College of the Holy Cross, in a keynote address.

New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes—not the presence of certain fats, but their suppression.

Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center investigators.

Dr. Timothy Ryan has been named one of eight academic principal investigators to participate in the SPARK NS Translational Research Program, 2025 cohort.